CinFina Pharma, a subsidiary of the hub-and-spoke biotech CinRx, shared early-stage data for two of its Janssen-licensed ...

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday ...

Maven Clinic laid off 60 people on Monday, Endpoints News has learned. The layoffs at the unicorn health tech startup ...

A panel of three judges on the US Court of Appeals for the Third Circuit didn't offer too many hints at which side it would ...

A day after Madrigal Pharmaceuticals impressed investors, Novo Nordisk is looking to steal the spotlight. The Danish ...

Generic drug manufacturers Heritage Pharmaceuticals and Apotex have agreed to pay $49.1 million to settle allegations from ...

Baxter has “suspended commercial activities” of its intravenous products in China to ease supply issues in the US caused by ...

Garuda Therapeutics has replaced its top leader and reeled in about $47 million to continue funding its blood stem cell ...

Generics giant Teva Pharmaceuticals has been hit with another fine related to its blockbuster multiple sclerosis drug ...

Donald Trump's embrace of Robert F. Kennedy Jr. is forcing biotech and pharma leaders to grapple with having US life sciences ...

Regeneron might be ready for competition with its blockbuster drug Eylea, but it's not clear that investors are. On Thursday ...

The US District Court for Washington, DC, on Wednesday ruled against Jazz Pharmaceuticals' attempt to undo the FDA's approval ...